Chase AIPricingFAQs
Display currency
Loading news…

DxS

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Manchester, United Kingdom Founded 2001 101-250 employees For Profit

DxS is a personalized medicine company providing molecular diagnostics to help doctors and drug companies select therapies for patients.

DxS was acquired by Qiagen in 2009 for $95M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
7
Active products
7
IT spend
$9M

Company Info

Founded
2001
Employees
101-250
Operating status
Closed
Company type
For Profit
Org types
company
News articles
4
HQ
Manchester, United Kingdom
Region
Europe, Middle East, and Africa (EMEA)
Exit date
Sep 29, 2009
Closed
Sep 29, 2009

Signals & Scores

Heat score
Low
Trend (7d)
-0.1
Trend (30d)
-0.6
Trend (90d)
-0.1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to DxS

Loading news…

FAQs about DxS

People who checked this page also checked these

Browse the full Acquirezy directory.
DxS - Company Profile, Full Acquisitions List, Funding and Investments